ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 32 filers reported holding ONCOCYTE CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $117,000 | +185.4% | 29,656 | 0.0% | 0.01% | +250.0% |
| Q4 2018 | $41,000 | -44.6% | 29,656 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $74,000 | +19.4% | 29,656 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | -55.1% | 29,656 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $138,000 | -38.4% | 29,656 | 0.0% | 0.01% | -42.9% |
| Q3 2017 | $224,000 | +45.5% | 29,656 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $154,000 | -12.5% | 29,656 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $176,000 | -15.8% | 29,656 | 0.0% | 0.01% | -20.0% |
| Q4 2016 | $209,000 | +40.3% | 29,656 | 0.0% | 0.02% | +25.0% |
| Q3 2016 | $149,000 | +101.4% | 29,656 | +43.3% | 0.01% | +100.0% |
| Q2 2016 | $74,000 | – | 20,696 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $27,155,000 | 4.50% |
| Family Management Corp | 20,550 | $155,000 | 0.11% |
| Artal Group S.A. | 150,000 | $1,133,000 | 0.02% |
| Destination Wealth Management | 29,656 | $224,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $1,095,000 | 0.01% |
| Carroll Financial Associates, Inc. | 850 | $5,000 | 0.00% |
| Advisor Group, Inc. | 112 | $1,000 | 0.00% |
| FIFTH THIRD BANCORP | 210 | $2,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,413 | $18,000 | 0.00% |